Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call Transcript

GPT Healthcare Earnings Call Transcript: Key Takeaways

GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.

Highlights
Revenue growth18.2% YoY growth to ₹126.2 Cr, driven by specialized tertiary care.
MarginsEBITDA margin at 20.4%; management targets 21% by fiscal year-end.
Demand visibilityStrong demand for tertiary care in underserved Eastern/Central India markets.
Management confidenceConfident but defensive regarding Raipur losses and Agartala occupancy fluctuations.

Growth

Revenue grew 18.2% YoY driven by complex quaternary procedures and robotic surgeries despite occupancy dips in Agartala.

Outlook

Targets 25% long-term ROE/ROCE; Jamshedpur facility (155 beds) commissioning in Q4 FY27.

Risks

High attrition in non-Kolkata markets (10% Agartala/Raipur) and continued losses (₹3 Cr) at the new Raipur facility.

Last quarter's promises, checked

Delivered

  • Guided 15% revenue growth → delivered 18.2% (= BEAT)
  • Guided Raipur breakeven by Q3 FY27 → delivered on track with losses narrowing (= BEAT)
  • Guided 70% occupancy in mature units → delivered 58-71% range (= BEAT)

Partly delivered

  • Guided 7-8% ARPOB growth → delivered 5.9% (= PARTIAL)
  • Guided Jamshedpur Q4 FY27 commissioning → delivered on track (= PARTIAL)

Missed

  • Guided 30% Raipur occupancy by year-end → delivered 14.26% (= MISS)
  • Guided 20.2% EBITDA margin → delivered 18.8% (= MISS)
Source

Earnings Call Transcript filed with BSE, NSE: GPTHEALTH. Summary written with AI assistance from the document.

Read the document ↗

GPT Healthcare Ltd: key numbers

Share price
₹161.27
Market cap
₹1,323 Cr
Revenue (annual)
₹472.6 Cr
Net profit (annual)
₹42.22 Cr
P/E (TTM)
28.0×Sector 57.8×
Promoter holding
65.57%+0.00% QoQ
FII holding
3.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from GPT Healthcare Ltd

All →